Brun MK, Bjørlykke KH, Viken MK, Stenvik GE, Klaasen RA, Gehin JE, Warren DJ, Sexton J, Sandanger Ø, Kvien TK, Mørk C, Haavardsholm EA, Jahnsen J, Goll GL, Lie BA, Bolstad N, Jørgensen KK, Syversen SW(2023) HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases J Intern Med, 293(5), 648-655 DOI 10.1111/joim.13616, PubMed 36843323
Viste R, Follin LF, Kornum BR, Lie BA, Viken MK, Thorsby PM, Rootwelt T, Christensen JAE, Knudsen-Heier S(2023) Increased muscle activity during sleep and more RBD symptoms in H1N1-(Pandemrix)-vaccinated narcolepsy type 1 patients compared with their non-narcoleptic siblings Sleep, 46(3) DOI 10.1093/sleep/zsac316, PubMed 36562330
Hajdarevic R, Lande A, Mehlsen J, Rydland A, Sosa DD, Strand EB, Mella O, Pociot F, Fluge Ø, Lie BA, Viken MK(2022) Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci Brain Behav Immun, 102, 362-369 DOI 10.1016/j.bbi.2022.03.010, PubMed 35318112
Get in touch
Contact information:
Project group leader Marte K. Viken, Oslo University hospital E-mail: m.k.viken@ous-research.no